PDUFA Dates: “Make-Or-Break Catalysts” For Biotech Stocks In October
Drugs for pain management, migraines, dry eye disease and Ebola are among those with PDUFA dates – deadlines by which the FDA must review new…
Drugs for pain management, migraines, dry eye disease and Ebola are among those with PDUFA dates – deadlines by which the FDA must review new…
Product candidates for the treatment of excessive underarm sweating on one hand, and dry eye disease on the other, could help the two stocks highlighted…
“Call it what you will, but I think traders who’ve dug into the biotech space initially came for the COVID, then figured out there’s far…
Today’s article highlights a biotech firm that, after being relatively quiet for several years, the market may begin to take notice of as it goes…
“We have a $5 billion market cap now. The next stage is for us to get to $20 billion,” declares the chief executive of the…
A biopharmaceutical company focused on addressing unmet needs in the fields of severe burns and other hard-to-heal wounds and a second biopharmaceutical company focused on…
The clinical-stage biotech highlighted in today’s article – operating in the hot immuno-oncology sector – has both long-term and short-term bull cases to be made…
“This is a market that favors stock picking over market timing and macro analysis,” advises the author of today’s article, who argues that “The business…
“One method of finding great stocks is to hunt down clinical stage companies with potential new treatment methods for diseases and ailments that affect large…
Of the most popular stocks on the Robinhood trading app, which boast the highest analyst ratings? Today’s article identifies the five most popular Robinhood stocks…